|
| Latest News |
| November 20, 2009 |
Updated Genetics of Spinal Muscular Atrophy Booklet Available Now | Click here to download a copy. |
|
|
|
| November 10, 2009 |
Families of Spinal Muscular Atrophy Funded Study Shows Quinazoline Compounds Give Survival Benefit in a Mouse Model of SMA. | Lead author Dr. Matthew Butchbach at the Ohio State University publishes SMA paper in the Journal Human Molecular Genetics. |
|
|
|
| November 4, 2009 |
Paratek Pharmaceuticals, Cold Spring Harbor Lab, Rosalind Franklin Researchers Publish on Tetracycline Drug Candidate for Spinal Muscular Atrophy. | First publication from the drug discovery collaboration at Paratek Pharmaceuticals that has been funded by Families of SMA. |
|
|
|
| November 2, 2009 |
FAQs from the Spinal Muscular Atrophy Community on Grassroots Support for the SMA Treatment Acceleration Act.
|
|
|
| October 22, 2009 |
Families of Spinal Muscular Atrophy Licenses Potential Treatment for SMA to Repligen Corporation. | Click here for the full press release. |
|
|
|
| October 15, 2009 |
Paratek Pharmaceuticals Inc. and Families of Spinal Muscular Atrophy Announce a Multi-Million Dollar Award. | From the National Institute of Neurological Diseases and Stroke to Advance a Drug Candidate for Spinal Muscular Atrophy. |
|
|
|
| October 14, 2009 |
California Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce Completion of Pre-IND Meeting with FDA. | For Stem Cell-Derived Therapy for the Treatment of Spinal Muscular Atrophy Type I. |
|
|
|
|
|
|
|
|
|
|
